Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/1/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. John C. Berridge

Wrong Dr. John C. Berridge?

ISPE Strategic Advisor and Member...

Phone: (813) ***-****  HQ Phone
Local Address:  United States
The International Society for Pharmaceutical Engineering Inc
600 N. Westshore Blvd. Suite 900
Tampa , Florida 33609
United States

Company Description: ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific,...   more

Employment History

Board Memberships and Affiliations


  • PhD
  • Ph.D.
63 Total References
Web References
Stephanie Wilkins, PE, (PharmaConsult ..., 1 Oct 2015 [cached]
Stephanie Wilkins, PE, (PharmaConsult US), former member of the ISPE International Board and co-Chair of the ISPE Risk-MaPP Baseline Guide Task Team, and ISPE Regulatory Advisor John Berridge, PhD, provided a presentation based on earlier ISPE comments.
John Berridge, ISPE ..., 9 Oct 2014 [cached]
John Berridge, ISPE Strategic Advisor and member of ISPE's Drug Shortages Task Team, knows all too well what the effects of a drug shortage can mean to patients after one of his medications became unavailable.
"A life-sustaining, medication, one that I have to take every day, became unavailable from the supplier," recalled Berridge. "It meant that I had to undergo a number of medical tests to determine which of the other available sources, and what dose of those sources, would be best since the efficacy and side effect profiles vary with the supplier. Finding a safe and suitable replacement took six weeks."
That caused great anxiety, said Berridge, who was an early advocate for investigating the root causes behind drug shortages and developing a shortage prevention plan for the pharmaceutical industry. His unfortunate experience also reminded him of how we take for granted a safe and available drug supply.
"Too often we assume that the drugs we need will always be available," said Berridge.
Speakers' Biographies - INTERPHEX Asia 2009 ISPE Singapore Conference 2009, 9 Dec 2009 [cached]
Dr. John Berridge European Regulatory Affairs Advisor ISPE
John retired from Pfizer Global Research & Development at Sandwich in January 2006 as Vice President of Pharmaceutical Sciences. He spent more than 31 years at Pfizer, starting as an Analytical Chemist, and ultimately responsible for all aspects of the product realisation disciplines of chemistry, pharmacy, analytical and regulatory CMC in Europe.
His research interests have been directed towards high performance liquid chromatography, with special emphasis on the use of chemometrics. This research was recognised by the award of the Chromatographic Society's Jubilee medal in 1989.
John was involved in the ICH processes from their inception until November 2007, representing EFPIA in the Quality topics discussions. He has contributed to guidelines on impurities in drug substances and their dosage forms, specifications, and the Common Technical Document (Quality): he was the Industry rapporteur for the pharmaceutical development guideline (Q8). In 1995 he was presented with an FIP IPS award for his outstanding contribution to industrial pharmacy and in 1997 he was awarded the Royal Pharmaceutical Society Chiroscience award for his services to the pharmaceutical industry. John now acts as an independent consultant and as European Regulatory Affairs Advisor to ISPE.
John will be presenting in Manufacturing Excellence: "Product Quality Lifecycle Implementation (PQLI) initiative - An Update" on 2 June 2009, Tuesday.
Ellsworth joins ISPE's two ... [cached]
Ellsworth joins ISPE's two other Regulatory Affairs Advisors, John Berridge and Bob Tribe.
John Berridge, PhD, is ISPE's European Regulatory Affairs Advisor, assisting ISPE in its interactions with European regulatory authorities as well as helping to move forward ISPE's new Product Quality Lifecycle Implementation (PQLI) initiative.Berridge retired from Pfizer Global Research and Development at Sandwich, England at the end of January 2006 as European Vice President of Pharmaceutical Sciences.
ISPE Launches PQLI Initiative to Facilitate Implementation of ICH Q8 and Q9 Guidelines | ISPE [cached]
These sessions are critically important opportunities to understand the latest developments from those directly involved in ICH and to contribute to clarifying the issues and opportunities of implementation," according to John Berridge, Pfizer Ltd., UK, Steering Committee Advisor.
John Berridge, PhD, Senior Regulatory Consultant, Pfizer, Inc. (EFPIA Advisor, SC)
Berlin Seminar Leaders will be John Berridge, Pfizer, UK, and Bruce Davis, AstraZeneca, UK.
John Berridge, Pfizer Ltd., UK
Other People with the name "Berridge":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.